期刊文献+

沙利度胺对类风湿关节炎T淋巴细胞的免疫调节作用 被引量:3

The immunoregulatory effects of thalidomide on T-lymphocytes of rheumatoid arthritis patients
原文传递
导出
摘要 目的探讨沙利度胺(Thd)对类风湿关节炎(RA)患者外周血T淋巴细胞的免疫调节作用。方法在植物血凝素(PHA)刺激下,RA患者外周血T淋巴细胞与不同浓度的Thd(2.5、25、100、300、500μg/ml)共同培养。用四甲基噻唑蓝(MTT)比色法检测T淋巴细胞的增殖,用流式细胞术检测T淋巴细胞的凋亡和T淋巴细胞CDl52、CD28的表达情况,用Real—time聚合酶链反应(PCR)检测T淋巴细胞的白细胞介素(IL)-6、IL-10、肿瘤坏死因子(TNF)一QmRNA表达水平。结果在体外,与阴性对照组相比,500μg/ml Thd组显著抑制T淋巴细胞的增殖,促进T淋巴细胞早期凋亡,抑制T淋巴细胞CD3+CD28+表达,促进CD8+CD152*3K达,而≤300μg/ml,对T淋巴细胞未见明显影响。与对照组相比,(100~500)μg/ml剂量组可抑制T淋巴细胞IL-6、TNF—dmRNA表达,(2.5~500)μg/ml可促进IL-10mRNA的表达。结论Thd可能通过影响RA患者外周血T淋巴细胞增殖、早期凋亡、CD3+CD28+和CD8+CD152+表达,以及IL-6、IL-10、TNF—dmRNA表达,反转RA患者的免疫平衡失控。 Objective To study the immunoregulatory effects of thalidomide on the peripheral blood T-lymphocytes of rheumatoid arthritis patients. Methods MTT was used to detect the effects of different thalidomide concentrations on the proliferation of T-cells. Flow cytometry was used to analyze T-cells early apoptosis and the T-cells subsets in different concentration of thalidomide. The mRNA expression of IL-6,1L- 10 and TNF-α was measured by RT-PCR method. Results The level of thalidomide at 500μg/ml inhibited the proliferation of T-cells and the CD3+CD28+ expression of T-cell subsets, but promoted the early apoptosis and the CD8+CD152+ expression of T-cell subsets. Thalidomine at any concentration could inhibit the mRNA expression of IL-6,TNF-α. However, the level of thalidomide that could promote the mRNA expression of IL- 10 was 100 μg/ml and 500 μg/ml, Conclusion Thalidomide can inhibit the proliferation of T lymphocytes and the expression of CD3+CD28+ on T-cell subsets. It can promote the early apoptosis and the CD8+CD152+ expression of T-cell subsets. Thalidomide inhibits the mRNA expression of IL-6 and TNF-α but promote the mRNA expression of IL-10. Thalidomide has immuno-regulatory effects on rheumatoid arthritis T-cells.
出处 《中华风湿病学杂志》 CAS CSCD 2008年第8期524-526,共3页 Chinese Journal of Rheumatology
基金 江苏省科技厅社会发展项目(BS2005043) 镇江市科技局社会发展项目(SH2004040) 镇江市重点医学人才资助项目(2005009)
关键词 沙利度胺 关节炎 类风湿 T淋巴细胞 免疫调节 Thalidomide Arthritis, rheumatoid T-lymphocytes Immunoregulatory
  • 相关文献

参考文献8

二级参考文献29

  • 1吴忠,李晶.缺氧诱导因子-1的功能及其在类风湿关节炎滑膜炎症中的作用[J].中华风湿病学杂志,2006,10(3):175-178. 被引量:4
  • 2D'Amato RJ, Loughnan MS, Flynn E, et al. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA, 1994, 91:4082-4085. 被引量:1
  • 3Kenyon BM, Browne F, D′Amato RJ. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp Eye Res, 1997, 64: 971-978. 被引量:1
  • 4Shore A, Jaglal S, Keystone EC. Enhanced interleukin 1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis. Clin Exp Immunol, 1986, 65: 293. 被引量:1
  • 5Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol, 1996, 14: 397. 被引量:1
  • 6Culy CR, Keating GM. Etanercept, updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis. Drugs, 2002, 62: 2493-2537. 被引量:1
  • 7Sampaio EP, Samo EN, Galily R, et al. Thalidomide selectively inhibits tumor necrosis factor-a production by stimulated human monocytes. J Exp Med, 1991, 173: 699-703. 被引量:1
  • 8Oliver SJ , Cheng TP, Banquerigo ML, et al. The effect of thalidomide and 2 analogs on collagen induced arthritis. J Rheumatol, 1998, 25: 964-969. 被引量:1
  • 9Fabro S, Schumacher H, Smith RL, et al. The metabolism of thalidomide: some biological effects of thalidomide and its metabolites. Br J Pharmacol, 1965, 25: 352-362. 被引量:1
  • 10Filaci G, Bacilieri S, Fravega M, et al. Impairment of CD8^+ T suppressor cell function in patients with active systemic lupus erythematosus[J]. J Immunol, 2001,166 : 6452-6457. 被引量:1

共引文献18

同被引文献44

  • 1Morel L. Genetics of human lupus nephritis. Semin Nephrol, 2007, 27: 2-11. 被引量:1
  • 2Yasui K, Kobayashi N, Yamazaki T, et al. Thalidomide as an immunotherapeutic agent: the effects on neutrophil-mediated inflammation.Curt Pharm Des. 2005, 11: 395-401. 被引量:1
  • 3Hirashima M, Fukazawa T, Abe K, et al. Expression and activity analyses of CTLA4 in peripheral blood lymphoeytes in systemic lupus erythematosus patients. Lupus, 2004, 13:24-31. 被引量:1
  • 4Bmnner-Weinzierl MC, Hoff H, Burmester GR. Multiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses: implications for arthritis and autoimmune diseases. Arthritis Res Ther, 2004, 6: 45-54. 被引量:1
  • 5Lopez P, Gomez J, Mozo L, et al. Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs. Arthritis Res Ther, 2006, 8: R42. 被引量:1
  • 6Aringer M, Smolen JS. Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus:a rationale for therapeutic intervention. Lupus, 2004, 13: 344-347. 被引量:1
  • 7Kim S S,Ye C,Kumar P,et al.Targeted delivery ofsiRNA to macrophages for anti-inflammatory treatment[J].Mol Ther,2010,18(5):993-1001. 被引量:1
  • 8Bourne T,Fossati G,Nesbitt A.A PEGylated Fab fragment against tumor necrosis factor for the treatment of Crohn Disease:Exploring a new mechanism of action[J].BioDrugs,2008,22(5):331-337. 被引量:1
  • 9Mukai Y,Nakamura T,Yoshikawa M,et al.Solution of the structure of the TNF-TNFR2 complex[J].Sci Signal,2010,3(148):ra83. 被引量:1
  • 10Lobo E D,Hansen R J,Balthasar J P.Antibody pharmacokinetics and pharmacodynamics[J].J Pharm Sci,2004,93(11):2645-2668. 被引量:1

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部